These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 34611216)
21. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166 [TBL] [Abstract][Full Text] [Related]
22. Lung microbiome dynamics in COPD exacerbations. Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613 [TBL] [Abstract][Full Text] [Related]
23. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease. Wu Y; Luo Z; Liu C Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175 [TBL] [Abstract][Full Text] [Related]
25. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease. Opron K; Begley LA; Erb-Downward JR; Li G; Alexis NE; Barjaktarevic I; Barr RG; Bleecker ER; Boucher R; Bowler RP; Christenson SA; Comellas AP; Criner G; Cooper CB; Couper D; Galban CJ; Han MK; Hastie A; Hatt C; Hoffman EA; Kaner RJ; Kesimer M; Krishnan JA; LaFon DC; Martinez FJ; Ortega VE; Peters SP; Paine R; Putcha N; Woodruff PG; Huffnagle GB; Kozik AJ; Curtis JL; Huang YJ; Am J Respir Crit Care Med; 2024 Jul; 210(2):186-200. PubMed ID: 38261629 [No Abstract] [Full Text] [Related]
26. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD. Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904 [TBL] [Abstract][Full Text] [Related]
27. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis. Byun MK; Chang J; Kim HJ; Jeong SH PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833 [TBL] [Abstract][Full Text] [Related]
28. Short term dynamics of the sputum microbiome among COPD patients. Sinha R; Weissenburger-Moser LA; Clarke JL; Smith LM; Heires AJ; Romberger DJ; LeVan TD PLoS One; 2018; 13(3):e0191499. PubMed ID: 29518088 [TBL] [Abstract][Full Text] [Related]
30. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation. Tufvesson E; Bjermer L; Ekberg M Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341 [TBL] [Abstract][Full Text] [Related]
31. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization. López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A; Respiration; 2019; 98(5):447-454. PubMed ID: 31437842 [TBL] [Abstract][Full Text] [Related]